Where am I?  > Home

Cleary and Slaughters pair up to advise Glaxo on $210m Egyptian acquisitions

Author: Emma Sadowski

30 Oct 2008 | 02:32 | secure

Cleary Gottlieb Steen & Hamilton and Slaughter and May have teamed up to advise GlaxoSmithKline (GSK) on its $210m (£128m) acquisition of some of Bristol Myers Squibb's (BMS's) Egyptian assets. The pair worked opposite DLA Piper on the deal, which sees GSK buying BMS's Egyptian mature products busi ...

This section of legalweek is available only to subscribers.


Sign up?

Subscribe

Subscribe today for all the business intelligence you need to stay ahead of your competitors.

Free trial

Register here for your FREE 4-week trial to Legal Weeks premium editorial.

*not available to current subscribers or previous trialists

Already registered?

Subscription options

Advertisement

SERVICES SECTION